The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis
The UK-PBC risk scores: derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis
The biochemical response to ursodeoxycholic acid (UDCA)--so-called "treatment response"--strongly predicts long-term outcome in primary biliary cholangitis (PBC). Several long-term prognostic models based solely on the treatment response have been developed that are widely used to risk stratify PBC patients and guide their management. However, they do not take other prognostic variables into account, such as the stage of the liver disease. We sought to improve existing long-term prognostic models of PBC using data from the UK-PBC Research Cohort. We performed Cox's proportional hazards regression analysis of diverse explanatory variables in a derivation cohort of 1,916 UDCA-treated participants. We used nonautomatic backward selection to derive the best-fitting Cox model, from which we derived a multivariable fractional polynomial model. We combined linear predictors and baseline survivor functions in equations to score the risk of a liver transplant or liver-related death occurring within 5, 10, or 15 years. We validated these risk scores in an independent cohort of 1,249 UDCA-treated participants. The best-fitting model consisted of the baseline albumin and platelet count, as well as the bilirubin, transaminases, and alkaline phosphatase, after 12 months of UDCA. In the validation cohort, the 5-, 10-, and 15-year risk scores were highly accurate (areas under the curve: >0.90).
Conclusions: the prognosis of PBC patients can be accurately evaluated using the UK-PBC risk scores. They may be used to identify high-risk patients for closer monitoring and second-line therapies, as well as low-risk patients who could potentially be followed up in primary care.
algorithms, cholangitis/complications, end stage liver disease/etiology, female, humans, male, middle aged, retrospective studies, risk assessment, ursodeoxycholic acid/therapeutic use
930-950
Carbone, Marco
2a402972-c971-4f89-94bc-a415f1ad0e8a
Sharp, Stephen J.
65e1326f-97f8-4654-b75c-15d046f00532
Flack, Steve
7f780220-f055-4583-8a23-29d3e687e54f
Paximadas, Dimitrios
d05ce36f-be9b-4f29-9379-cfea0d3a0923
Spiess, Kelly
2c486673-c7e2-49a5-a697-16108355f0ab
Adgey, Carolyn
47b742ac-cdc3-4613-bd15-e64bbb641648
Griffiths, Laura
6ad12542-2148-4158-adf5-92e6021ed120
Lim, Reyna
69f39af3-efd1-47df-98a9-14e9f6f5bae7
Trembling, Paul
8f2dd90c-6124-4c70-a76b-057b6e90867c
Williamson, Kate
08926456-e569-47be-95c2-da7b22c6b319
Wareham, Nick J.
a1f361fa-e5e6-40c6-be7b-b4fb61bd0924
Aldersley, Mark
72a9c3f4-f70a-477f-82bc-cfb4bf2ae8fe
Bathgate, Andrew
577649e0-e281-43fd-ae3e-46c915e33031
Burroughs, Andrew K.
531a7a81-77ef-4188-ab96-352ea7412f50
Heneghan, Michael A.
02ca4e3b-ddee-4d6d-90fa-6880c05bf12c
Neuberger, James M.
5767dd7d-609d-41e5-85e9-8d504063a912
Thorburn, Douglas
3541a9b1-15f0-4577-83b3-3f6aaa3a5f8a
Hirschfield, Gideon M.
bb9e925a-5674-4bad-8880-45e86f515948
Cordell, Heather J.
0c13b4c1-417f-49e5-aa74-34e1936da81a
Alexander, Graeme J.
3373aaa7-0249-4edd-b88f-a63677f32bba
Jones, David E.J.
8e1bfc3f-30e9-4549-93c4-1b466b2bdc15
Sandford, Richard N.
1f9a5d2b-d14a-43b3-b326-fa9ab17b406f
Mells, George F.
63e52765-505a-4ae6-af08-484cf4c46059
Wright, Mark
43325ef9-3459-4c75-b3bf-cf8d8dac2a21
1 March 2016
Carbone, Marco
2a402972-c971-4f89-94bc-a415f1ad0e8a
Sharp, Stephen J.
65e1326f-97f8-4654-b75c-15d046f00532
Flack, Steve
7f780220-f055-4583-8a23-29d3e687e54f
Paximadas, Dimitrios
d05ce36f-be9b-4f29-9379-cfea0d3a0923
Spiess, Kelly
2c486673-c7e2-49a5-a697-16108355f0ab
Adgey, Carolyn
47b742ac-cdc3-4613-bd15-e64bbb641648
Griffiths, Laura
6ad12542-2148-4158-adf5-92e6021ed120
Lim, Reyna
69f39af3-efd1-47df-98a9-14e9f6f5bae7
Trembling, Paul
8f2dd90c-6124-4c70-a76b-057b6e90867c
Williamson, Kate
08926456-e569-47be-95c2-da7b22c6b319
Wareham, Nick J.
a1f361fa-e5e6-40c6-be7b-b4fb61bd0924
Aldersley, Mark
72a9c3f4-f70a-477f-82bc-cfb4bf2ae8fe
Bathgate, Andrew
577649e0-e281-43fd-ae3e-46c915e33031
Burroughs, Andrew K.
531a7a81-77ef-4188-ab96-352ea7412f50
Heneghan, Michael A.
02ca4e3b-ddee-4d6d-90fa-6880c05bf12c
Neuberger, James M.
5767dd7d-609d-41e5-85e9-8d504063a912
Thorburn, Douglas
3541a9b1-15f0-4577-83b3-3f6aaa3a5f8a
Hirschfield, Gideon M.
bb9e925a-5674-4bad-8880-45e86f515948
Cordell, Heather J.
0c13b4c1-417f-49e5-aa74-34e1936da81a
Alexander, Graeme J.
3373aaa7-0249-4edd-b88f-a63677f32bba
Jones, David E.J.
8e1bfc3f-30e9-4549-93c4-1b466b2bdc15
Sandford, Richard N.
1f9a5d2b-d14a-43b3-b326-fa9ab17b406f
Mells, George F.
63e52765-505a-4ae6-af08-484cf4c46059
Wright, Mark
43325ef9-3459-4c75-b3bf-cf8d8dac2a21